Navigation Links
Barr Announces Reorganization of Senior Management, Business Functions
Date:3/28/2008

ing from challenging the validity or non- infringement of patents covering our products; the difficulty of predicting the timing of FDA approvals; court and FDA decisions on exclusivity periods; the ability of competitors to extend exclusivity periods for their products; our ability to complete product development activities in the timeframes and for the costs we expect; market and customer acceptance and demand for our pharmaceutical products; our dependence on revenues from significant customers; reimbursement policies of third party payors; our dependence on revenues from significant products; the use of estimates in the preparation of our financial statements; the impact of competitive products and pricing on products, including the launch of authorized generics; the ability to launch new products in the timeframes we expect; the availability of raw materials; the availability of any product we purchase and sell as a distributor; the regulatory environment in the markets where we operate; our exposure to product liability and other lawsuits and contingencies; the increasing cost of insurance and the availability of product liability insurance coverage; our timely and successful completion of strategic initiatives, including integrating companies (such as PLIVA d.d.) and products we acquire and implementing our new SAP enterprise resource planning system; fluctuations in operating results, including the effects on such results from spending for research and development, sales and marketing activities and patent challenge activities; the inherent uncertainty associated with financial projections; our expansion into international markets through our PLIVA acquisition, and the resulting currency, governmental, regulatory and other risks involved with international operations; our ability to service our significantly increased debt obligations as a result of the PLIVA acquisition; changes in generally accepted accounting principles; and other risks detailed in our SE
'/>"/>
SOURCE Barr Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... (PRWEB) August 30, 2014 Insomnia causes disturbances ... listeners understand how they unknowingly developed insomnia and the steps ... nights during. Tune in to the show at this ... show airs live on August 30, and will be podcasted ... on programming, go to DrCarolFrancisTalkRadio.com. , "Insomnia causes ...
(Date:8/30/2014)... Springs, CO (PRWEB) August 30, 2014 In ... and increasingly difficult to get. Snoring and sleep apnea (a ... stops) rob people and their bed partners of the rest ... to 45% of the population snores and 20 million people ... only 10% have been diagnosed and treated; and of those ...
(Date:8/30/2014)... medication commonly used to treat gout, before and ... potential complications from this type of surgery, but ... effects, according to a study published by ... online to coincide with its presentation at the ... after cardiac surgery include postpericardiotomy syndrome (the occurrence ...
(Date:8/30/2014)... August 30, 2014 Serving contented clients ... India, Profit By Outsourcing is now offering discount ... The company gives emphasize on putting forward the best ... to clients. Their dedicated team of professionals and web ... They can handle even the critical issues of web ...
(Date:8/30/2014)... Pittsburgh, PA (PRWEB) August 30, 2014 "I ... beach because of her crutches," said an inventor from Wetumpka, ... the sights and sounds of the shore, I came up ... beach sand." , She created a prototype for the patent-pending ... The accessory enables the individual to use crutches, walkers, or ...
Breaking Medicine News(10 mins):Health News:Sleepless Nights, Exhausting Days, Mental Fog – Relief for Insomnia With Clinical Psychologist Dr. Carol Francis 2Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Medication shows mixed results in reducing complications from cardiac surgery 2Health News:Profit By Outsourcing Offering Discount for Labor Day on all Web Development Services 2
... Stock Exchange Symbol: CYT, MONTREAL, Oct. ... leader in cardiac arrhythmia products to treat ... Inc. a patent,infringement lawsuit in the United ... CryoCor makes and sells cryosurgical consoles, ...
... Oct. 16 Genzyme Corporation,(Nasdaq: GENZ ) ... Advisory Committee meeting, during which the committee voted ... the FDA extend the indications,for phosphate binders to ... Renagel(R) (sevelamer hydrochloride), the most,prescribed phosphate binder in ...
... Squirrel Hill Facility and Expand Programs ... ... Institute announced,the launch of the public phase of The Campaign for ... of pediatric,rehabilitation services in western Pennsylvania, The Children,s Institute,will use the ...
... ... IRVINE, Calif., Oct. 16 Edwards Lifesciences,Corporation ... products and technologies to,treat advanced cardiovascular disease, today ... Foundation,s (CRF) nineteenth,annual Transcatheter Cardiovascular Therapeutics (TCT) scientific,symposium, ...
... With both the Senate and,House expected to vote this ... Health Insurance Program (SCHIP) legislation, U.S.,Senator Sherrod Brown (D-OH) ... came together on a news conference call to urge ... The SCHIP legislation would provide $35 billion in ...
... to all approved drugs used to fight ear infections ... tomorrow in the Journal of the American Medical Association ... it is their standard practice to perform an uncommon ... antibiotics fail to clear up their ear infections. The ...
Cached Medicine News:Health News:Genzyme Statement Regarding Results of FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease 2Health News:Genzyme Statement Regarding Results of FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease 3Health News:The Children's Institute Launches The Campaign for an Amazing Future 2Health News:The Children's Institute Launches The Campaign for an Amazing Future 3Health News:Edwards Lifesciences Announces Schedule of Activities at TCT 2007 2Health News:Edwards Lifesciences Announces Schedule of Activities at TCT 2007 3Health News:Edwards Lifesciences Announces Schedule of Activities at TCT 2007 4Health News:Ohio Delegation Members Urge Colleagues to Vote for Override of SCHIP Veto 2Health News:Ear infection superbug discovered to be resistant to all pediatric antibiotics 2Health News:Ear infection superbug discovered to be resistant to all pediatric antibiotics 3Health News:Ear infection superbug discovered to be resistant to all pediatric antibiotics 4
(Date:8/29/2014)... Diseases largely eradicated in the ... Measles was declared eliminated in 2000, yet the CDC ... 15—the highest incidence in 20 years. In July, ... cough a problem of "epidemic proportions." ... from these preventable diseases—in part because some parents (more ...
(Date:8/29/2014)... Aug. 29, 2014 /PRNewswire-iReach/ -- ChemImage will present a ... and New Zealand Forensic Science Society,s 22 nd ... Adelaide, Australia .  Forensic Scientists ... advancements that hyperspectral imaging can bring to examination ... , Director of Product Development at ChemImage, will ...
(Date:8/29/2014)...  In part four of a blog ... as a strategic asset, Mary Baxter, MBA, RPh ... Health,s Innovation Delivery Solutions business, discusses how expanding patient ... and patients. "Every hospital pharmacist knows that ... job in a value-based healthcare world," Baxter says. "For ...
Breaking Medicine Technology:Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 2Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 4
Rapid test for the presumptive identification of Candida albicans from culture media....
... Virion\Serions comprehensive line of ELISA Classic serology ... viral, and fungal pathogens with rapid, standardized ... IgA antibodies. All of the ELISA antigens ... in their own laboratories under the control ...
Rapid reagent impregnated disk test for presumptive identification of Candida albicans....
Immunodiffusion tests are used for the detecion of precipitating antibodies (primarily of the IgG and IgA classes) against antigens of C. albicans. The presence of precipitating antibodies indicates ...
Medicine Products: